Headlands Technologies’s Vir Biotechnology VIR Stock Holding History

Headlands Technologies’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$925K	Buy	103,247 +80,691	+358%	+$643K	0.11%	221
2025 Q4	$136K	Buy	+22,556	New	+$134K	0.01%	616
2025 Q3	–	Sell	-1,573	Closed	-$7.93K	–	1277
2025 Q2	$7.93K	Sell	1,573 -26,518	-94%	-$142K	﹤0.01%	1035
2025 Q1	$182K	Sell	28,091 -4,341	-13%	-$38.6K	0.02%	472
2024 Q4	$238K	Buy	32,432 +20,984	+183%	+$166K	0.02%	489
2024 Q3	$85.7K	Sell	11,448 -20,841	-65%	-$181K	0.01%	701
2024 Q2	$287K	Buy	32,289 +20,556	+175%	+$197K	0.03%	390
2024 Q1	$119K	Buy	+11,733	New	+$119K	0.03%	505

Other funds holding VIR

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return